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Chromosome 22 has been implicated in schizophrenia and bipolar disorder in a number of
linkage, association and cytogenetic studies. Recent evidence has also implicated CAG repeat
tract expansion in these diseases. In order to explore the involvement of CAG repeats on
chromosome 22 in these diseases, we have created an integrated map of all CAG repeats 5
on this chromosome together with microsatellite markers associated with these diseases
using the recently completed nucleotide sequence of chromosome 22. Of the 52 CAG repeat
loci identified in this manner, four of the longest repeat stretches in regions previously impli-
cated by linkage analyses were chosen for further study. Three of the four repeat containing
loci, were found in the coding region with the CAG repeats coding for glutamine and were
expressed in the brain. All the loci studied showed varying degrees of polymorphism with
one of the loci exhibiting two alleles of 7 and 8 CAG repeats. The 8-repeat allele at this locus
was significantly overrepresented in both schizophrenia and bipolar patient groups when
compared to ethnically matched controls, while alleles at the other three loci did not show
any such difference. The repeat lies within a gene which shows homology to an androgen
receptor related apoptosis protein in rat. We have also identified other candidate genes in the
vicinity of this locus. Our results suggest that the repeats within this gene or other genes in
the vicinity of this locus are likely to be implicated in bipolar disorder and schizophrenia.
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Introduction
Bipolar disorder and schizophrenia are severe
behavioral disorders which have a complex inherit-
ance pattern and a uniform worldwide prevalence rate
of 1%. A genetic component for these disorders has
been established on the basis of family and twin stud-
ies and numerous strategies have been attempted to
identify the genes responsible for these diseases. These
include linkage analysis as well as candidate gene and
association studies. Both these approaches have
yielded results that have not been readily reproducible
in different sample sets.1–3
A few loci however, have been repeatedly implicated
in bipolar disorder and schizophrenia by independent
studies. One of the most intensively studied regions
amongst these include several loci on chromosome 22.4
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Initial genome wide scans for schizophrenia by differ-
ent groups suggested possible linkage for markers on
chromosome 22q although neither of the groups
reported statistically significant results.4–6 A combined
transmission disequilibrium and linkage analysis of
D22S278 in 574 families further strengthened the
possibility of a susceptibility locus on chromosome
22q.7 While a number of further reports have failed to
reproduce these results, others have demonstrated
positive linkage findings for markers spread through-
out chromosome 22q using various methods of analy-
ses.3,4 In the case of bipolar disorder, parametric analy-
sis yielded a maximum lod score of 3.8 at D22S278
providing evidence for significant linkage to this chro-
mosome.8
A further line of evidence implicating chromosome
22 in schizophrenia has come from the study of
patients with a congenital malformation called velo
cardio facial syndrome (VCFS). VCFS is known to be
caused by deletions in the region of 22q11.2–q11.23
and patients suffering from this disorder show a high
prevalence of psychiatric illnesses including both
bipolar disorder and schizophrenia.9–11 A sampling of
100 schizophrenic patients identified the presence of
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interstitial deletions ranging from 1.5–2 Mb in the
region of chromosome 22q11 in two of the patients.12
Although large-scale epidemiological studies have not
been carried out, initial studies have suggested that the
frequency of chromosome 22 deletions may be 80 times
higher than the general population.11–14 Linkage analy-
ses have also suggested a possible locus for bipolar dis-
order in the VCFS region.15 Taken together, these inde-
pendent lines of evidence from cytogenetic studies and
linkage analysis studies suggest that chromosome 22
might indeed harbour susceptibility loci for schizo-
phrenia and bipolar disorder.
Apart from linkage studies an alternative approach
which has evoked a great deal of interest in recent
years has been the study of trinucleotide repeat expan-
sions in bipolar disorder and schizophrenia.16 To date,
more than a dozen neurological disorders have been
shown to be caused by trinucleotide repeat expansions
with the CAG repeat being the most frequently
involved triplet. When the CAG triplet occurs in the
coding regions, expansion results in long polygluta-
mine stretches which are thought to mediate the dis-
ease process.17–19 One of the most important features
common to these diseases and bipolar disorder and
schizophrenia is the phenomenon of antici-
pation.16,20,21 This inheritance pattern refers to the
increase in disease severity with a reduction in the age
at onset when the disease is transmitted in successive
generations. The molecular basis for anticipation was
elucidated with the discovery of trinucleotide repeat
expansions where the increase of repeat number during
intergenerational transmission results in the increased
disease severity and a reduced age at onset.17,21
Studies of anonymous CAG repeats using the repeat
expansion detection (RED) technique have demon-
strated expanded repeats in schizophrenia and bipolar
disorder with considerable overlap between patients
and controls.22–24 A great deal of effort has focused on
the identification of loci containing trinucleotide
repeats as candidate genes for these diseases. The can-
didate gene approach however, has been unable to
demonstrate large expansions of trinucleotide repeats
in the range of those seen in the diseases caused by
triplet repeat expansions in patients suffering from
schizophrenia and bipolar disorder.16 The failure to
observe large expansions has led to suggestions that it
might be worthwhile studying moderate trinucleotide
repeat expansions in patients suffering from these dis-
eases.25 We have also earlier proposed that a difference
in allele sizes or ‘allele span’ at such polymorphic tri-
nucleotide repeat loci may also be implicated in
bipolar disorder and schizophrenia.26,27
As chromosome 22 has been repeatedly implicated
in bipolar disorder and schizophrenia, we sought to
test the hypothesis that susceptibility loci on this chro-
mosome might contain expanded CAG repeats
involved in the pathogenesis of these disorders. Taking
advantage of the recent availability of the complete
sequence of chromosome 2228 we have mapped all
CAG repeats 5 on this chromosome and studied the
longest of these repeat tracts in regions previously
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implicated in bipolar disorder and schizophrenia and
coding for genes expressed in the brain.
Materials and methods
Selection of patients and controls
A total of 108 bipolar patients (59 males and 49
females, mean age: 31.8 ± 12.1 years, age at onset:
21.8 ± 7.8 years) and 108 schizophrenia patients (58
males and 50 females, mean age: 30.8 ± 10.2 years,
mean age at onset: 23.0 ± 10.2 years) were used in the
study. Depending on the loci analyzed, the number of
subjects ranged from 100–107 patients with bipolar
disorder and 103–106 patients with schizophrenia
(Table 1). All patients were of Indian origin and were
recruited from the clinical services of the National
Institute of Mental Health and Neuroscience, Banga-
lore, India. Diagnoses were made using OPCRIT ver.
3.329 after a personal interview and examination of case
notes. All patients fulfilled the ICD-10 criteria for
bipolar disorder or schizophrenia. All bipolar patients
had a history of at least one previous manic episode,
and thus could be seen as bipolar type 1 phenotype.
The number of normal individuals ranged from 106–
120 taken from a total 129 normal subjects (85 males
and 44 females, mean age: 34.5 ± 16.7 years). Controls
were recruited from a voluntary blood donation camp
and were all of South Indian origin as were the patients
in order to reduce any effect of genetic heterogeneity.
Normal subjects were interviewed to exclude any his-
tory of psychiatric illness. Informed consent was
obtained from patients and controls before carrying out
the study. Some of the patients and controls have been
used in earlier published studies.26,27 The number of
patient and control samples used for the individual
loci are given in Table 1.
Identification and selection of CAG repeats on
chromosome 22
The complete nucleotide sequence of chromosome 22
was obtained through ftp from The Sanger Centre
(ftp://sanger.ac.uk) and the file used for the present
analysis was Chr 22 01-12-1999.fa.gz which con-
tained the full chromosome 22 nucleotide sequence.
Custom PERL (Practical Extraction and Reporting
Language) scripts were written to identify sequences
containing five or more continuous CAG or CTG
repeats. The sequences were then extracted along with
400 bp of unique sequence upstream and downstream
of the repeat region. The coding status of the repeat
containing regions was determined from the existing
gene annotation and in case the repeats were found in
the coding region, they were searched for in the EST
database to check whether they were expressed in the
brain. After obtaining CAG repeats and their positions
along chromosome 22, a map was constructed superim-
posing these CAG repeats with microsatellite markers
and genes already implicated in schizophrenia and
bipolar disorder. The CAG repeat sizes on this map cor-
respond to the repeat number obtained from Sanger
centre sequence data. The list of markers implicated in
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Table 1 Details of samples and PCR conditions for selected CAG repeat loci on chromosome 22
CAG repeat No. of samples used PCR primers used Annealing Expected size
locus temp (°C) (bp)
BP SZ NC
22CH4 100 106 106 FP 5 ACC GAG TGC TGC TTG TTC TGC CT 3 62 420 (13 repeats)
RP 5 GCG GCT GGT GGT GCT GTG 3
22CH1 105 106 111 FP 5 CTG GGC TGC TGG GCT GCT GAG 3 60 438 (13 repeats)
RP 5 GTC GCT GCT AAC CGG TGA GAA TCC 3
22CH2 107 103 107 FP 5 GGC GGC GGA TGC GGA CCT GA 3 55 488 (9 repeats)
RP 5 ATG CAC AAC GGC GCT CTG GAT AAT 3
22CH3 100 103 120 FP 5 AAC CGG GCA CAG TCT TTT C 3 55 470 (8 repeats)
RP 5 AGG CCT GGC TCT GCT ATT TA 3
BP, bipolar disorder; SZ, schizophrenia; NC, normal controls.
both the disorders was obtained from the Chromosome
22 workshop Report, 1999.4 The primer sequences
which amplify these microsatellite loci were used to
identify the positions of these markers along chromo-
some 22 using the chromosome 22 specific BLAST pro-
gram available at http://sanger.ac.uk. In some cases we
were unable to identify the primer sequences using
BLAST and these markers were not included in the
map. The order of the markers identified in this man-
ner was found to be accurate to the limits of genetic
mapping. BLAST homology searches for unknown
ORFs were performed using web-based programs avail-
able at http://www.ncbi.nlm.nih.gov.
CAG repeat size estimation
Ten millilitres of blood were obtained from patients
and controls and DNA extracted using a modification
of the salting out method.30 PCR primers were designed
for the loci containing CAG repeats using the Primer
Select Program (DNASTAR, Madison, WA, USA). The
PCR products were fluorescently labeled either using
fluorescently labeled primers or fluorescent dUTP. All
PCR reactions were carried out with an initial denatur-
ation of 94°C for 3 min followed by 35 cycles of denat-
uration and extension steps of 94°C and 72°C, respect-
ively, for 30 s. The annealing step was carried out for
30 s and temperature varied with the locus used. The
reaction was completed with extension at 72°C for
10 min. The details of the primers used for each locus,
the annealing temperatures and expected size of the
PCR products are given in Table 1. PCR products for
each locus were diluted and mixed together and loaded
in the same lane. Sizing was carried out using the
Genescan software on an ABI Prism 377 Automated
DNA sequencer (Perkin Elmer, Foster City, USA) with
a TAMRA labeled marker (CBT 550) run in each lane.
Heterozygosity indices were calculated using the for-
mula 1− pi2 where pi represents the frequency of the
ith allele. Chi-square tests were used to determine sig-
nificance of association between alleles in patients and
controls at the various loci studied with correction
applied for multiple testing. ANOVA tests with a post
hoc Newman–Keuls comparison were also used to
compare patient and control populations.
Results
Fifty-two loci were identified on chromosome 22
which contained five or more continuous CAG repeats
with 13 repeats being the longest stretch found. Five
repeats was the most common length accounting for
55.7% of the loci identified followed by six repeats
(21.1%), seven repeats (9.6%), eight repeats (5.8%),
nine repeats (3.8%) and 13 repeats (3.8%). The map of
the CAG repeats together with microsatellite markers
and genes previously implicated in schizophrenia and
bipolar disorder are shown in Figure 1. Of the 52, four
of the longest loci were chosen for further study. The
details of the four loci are given in Table 2. We have
chosen the longest CAG repeat tracts as it is well
known that the longer tracts are more likely to be poly-
morphic. Thus, the loci 22CH1 and 22CH4 which con-
tain 13 CAG repeats as the reported size were chosen
because they were the longest tracts on chromosome 22
and were also in the proximity of markers previously
implicated in bipolar disorder and schizophrenia.
22CH1 lies in a non coding region while the CAG
repeats at 22CH4 lie within an ORF encoding 733
amino acids, with the CAG repeats coding for gluta-
mine. This protein shows partial identity to a human
Transcriptional Adaptor protein isolated from placenta
and bone marrow (GenBank Acession No. 7706225).
The mRNA for this repeat-containing region was also
identified in a study designed to pick up CAG repeat-
containing genes expressing in the brain.31 The loci,
22CH2 and 22CH3 containing nine and eight repeats,
respectively, were chosen over 22CH5 (eight CAG
repeats) and 22CH6 (nine CAG repeats) because both
of the former were in the vicinity of previously impli-
cated markers. Furthermore, both 22CH2 and 22CH3
were found in the coding regions and were expressed
in the brain, with the repeats coding for glutamine. The
CAG repeat at 22CH2 is part of a gene MNI (GenBank
Accession No. 4505222) which is 1343 amino acids
long and is involved in the pathogenesis of meningi-
oma brain tumors (OMIM No. 156100). The repeats at
22CH3 are part of a predicted gene encoding 1203
amino acids. A BLAST analysis revealed that the C ter-
minal 248 amino acids of this protein show a 97%
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Figure 1 Distribution of all CAG repeats 5 on chromosome 22q together with microsatellite markers implicated in schizo-
phrenia or bipolar disorder. Arrows indicate CAG repeat loci chosen for study. The bars below the x axis represent microsatellite
markers, with the longer bars marked with asterisks indicating markers having lod scores or NPL values 2 or P values 0.01.
The x axis represents the distance in Mb along the length of chromosome 22q with the 0 position corresponding to the centro-
mere. The sequenced portion of Chr22q extends to a length of 33.4 Mb. The y axis represents length of the CAG repeat tract
as reported in the Sanger centre database.
Table 2 Details of the four chosen CAG repeat loci on chromosome 22
CAG repeat Location along Coding status Size range of alleles Heterozygosity
locus chromosome 22 (bp) in CAG repeat units index
(No. of alleles)
22CH4 4 497 628 Coding (CAG codes for glutamine) 12–17 (5) 0.39
22CH1 7 608 653 Non-coding (intergenic) 8–20 (6) 0.48
22CH2 11 734 903 Coding (CAG codes for glutamine) 2–19 (8) 0.20
22CH3 24 119 007 Coding (CAG codes for glutamine) 7–8 (2) 0.45
identity to an androgen-related apoptosis protein in rat
(GenBank Accession No. 9295519). The transcript
encoding this gene has been found to be expressed in
the human brain.32
The CAG repeat lengths at these four loci were esti-
mated in normal controls, bipolar and schizophrenic
patients (Figure 2). All the loci studied were polymor-
phic; the number of alleles and heterozygosity indices
of these loci are given in Table 2. Except for 22CH1
where 12 repeats rather than the 13 repeats was the
modal allele, all the loci had modal alleles correspond-
ing to the repeat number in the database sequence.
Both 22CH1 and 22CH4 showed a near bimodal distri-
bution with 12 and 13 repeats in the case of 22CH1
and 13 and 14 repeats in the case of 22CH4 accounting
for the majority of alleles. In the case of 22CH2, an
almost unimodal distribution was observed with the
majority of alleles corresponding to nine repeats. How-
ever, a schizophrenia patient having a size correspond-
ing to two repeats and a normal individual with 19
repeats were observed at this locus. Unlike the other
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loci, 22CH3 was unique in that it was purely bi-alleleic
exhibiting alleles of seven and eight repeats. The allele
frequencies and genotype frequencies for this locus are
given in Table 3. The genotype frequencies at this locus
were in Hardy–Weinberg equilibrium in both groups of
patients and controls.
No large expansions of the range observed in the tri-
nucleotide repeat disorders were seen in the patient
group in any of the loci studied. Of the four loci, we
could find a significant difference between the patients
and control groups only in the case of 22CH3. At this
locus, the allele frequencies varied significantly
between both the patient groups and controls (bipolar
vs control: 2 = 5.39, df = 1, P  0.02; schizophrenia vs
control: 2 = 5.19, df = 1, P  0.02). These results were
sustained after correcting for multiple testing. An
ANOVA test at this locus with a post hoc Newman–
Keuls comparison indicated that both patient groups
did not differ from each other but were significantly
different from the control groups (P = 0.018). The geno-
type frequencies were significantly different in bipolar
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Figure 2 Distribution of CAG repeats at four selected loci in normal individuals, bipolar and schizophrenia patients. The
bottom x axis represents CAG repeat number while the top x axis represents number of glutamine residues. The y axis represents
% frequency of alleles.
Table 3 Allele and genotype frequencies for the locus
22CH3
Allele frequencies Genotype frequencies
7 repeat 8 repeat 7/7 7/8 8/8
Schizophrenia 0.30 0.70 0.09 0.42 0.49
Bipolar 0.29 0.71 0.10 0.38 0.52
Normal 0.40 0.60 0.16 0.49 0.35
patients as compared to controls but in patients with
schizophrenia this difference did not reach statistical
significance at the 5% level (genotype frequencies:
bipolar vs control 2 = 6.25, df = 2, P = 0.04; schizo-
phrenia vs control 2 = 5.69, df = 2, P = 0.06). The 8-
repeat allele and the 8/8 genotype were found to be
overrepresented in the patient group as compared to
the controls.
Discussion
We have analyzed the possible association of CAG
repeat polymorphisms on chromosome 22 with schizo-
phrenia and bipolar disorder. We were able to identify
52 loci containing five or more continuous CAG
repeats. Of the 52, four of the longest repeat tracts in
the vicinity of markers previously implicated in these
diseases were selected for further study. In three of
these four loci the CAG tracts were part of genes
expressed in the brain and coding for glutamine resi-
dues. This makes them ideal candidate genes for
schizophrenia and bipolar disorder as expanded gluta-
mine repeats have been associated with neuro-degener-
ative disorders and novel proteins with expanded poly-
glutamine tracts have been identified in patients with
schizophrenia.16,33
All the loci we have studied were polymorphic
although the heterozygosity is not as high as that seen
in most of the diseases associated with unstable trinu-
cleotide repeats.34 We were unable to observe any
large-scale expansion in the patients as compared to
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the normals. This does not, however rule out these loci
as candidates for trinucleotide repeat expansions. In
the case of SCA2, expansions are observed in diseased
individuals in spite of the low heterozygosity observed
for the normal alleles at this locus.34 The nine pure
CAG repeats at 22CH2 are part of a tract of 27 gluta-
mine residues in the MN1 gene coded for by additional
stretches of short CAG repeats interrupted by CAA
codons. In one of the normal samples, this pure CAG
repeat stretch was expanded to 19 repeats correspond-
ing to a total of 37 glutamine residues. This range is
at the threshold of polyglutamine repeats above which
disease onset is observed in the majority of the dis-
orders caused by polyglutamine expansions.17 The
22CH2 locus might therefore be a putative candidate in
the other diseases where unstable trinucleotide repeats
have been implicated.
Except in the case of 22CH3 there was no significant
difference in allele frequencies between patients and
ethnically matched controls at the loci studied. At the
22CH3 locus only two alleles of seven and eight repeats
were observed in both patient and control groups. The
8-repeat allele and the 8/8 genotype were significantly
overrepresented in both bipolar and schizophrenia
patients when compared to normal controls. The repeat
lies at a position of 24 119 007 bp along the length of
chromosome 22 in the vicinity of the markers D22s279
(24 443 698 bp) and D22s276 (25 500 500 bp) which
have been previously implicated in schizophrenia.
This is part of a region around the markers D22s278
(19 857 258 bp) to D22s279 where a large number of the
positive findings on schizophrenia are concentrated
and also includes a locus for bipolar disorder.4 It is
interesting that our findings of a positive association
for both disorders at the same locus mirror these pre-
vious reports. This is one of the few chromosomal
locations where there is an overlap of loci for bipolar
disorder and schizophrenia and raises the possibility
that these diseases may share some common suscepti-
bility genes.35
The functional significance of the repeat variation at
22CH3 is difficult to ascertain as the CAG repeats are
part of a novel protein whose function is yet unknown.
We find that this protein shows partial identity to an
androgen-related apoptosis protein in rat. It is therefore
only possible to speculate whether this gene is itself
involved in the pathogenesis of schizophrenia or
whether the repeat variation is merely a marker
implicating other genes in the vicinity. Chromosome
22 is particularily gene dense and a 2 Mb region sur-
rounding the 22CH3 CAG repeat contains 36 genes and
four pseudo genes,28 a number of which might be puta-
tive candidates for bipolar disorder and schizophrenia.
This includes a gene for a voltage-dependent alpha II
subunit of a calcium channel. Calcium channels have
been previously implicated in bipolar disorder and
schizophrenia.27 The gene which encodes synaptogyrin
1, a protein which is involved in presynaptic vesicle
formation in neurons,36 is also found within 2 Mb of
the 22CH3 locus. While this manuscript was under
review, Mirnics et al reported altered levels of synapto-
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gyrin 1 in the prefrontal cortex of some of the patients
suffering from schizophrenia using microarray analy-
sis.37 Neuro-developmental and synaptic regulatory
mechanisms are important to our understanding of
schizophrenia and thus synaptogyrin 1 appears to be
an attractive candidate for schizophrenia susceptibility
and needs to be investigated further. Also lying adjac-
ent to the CAG repeat-containing gene at the 22CH3
locus is the adenylosuccinate lyase gene which has
been shown to be involved in autism and psychomotor
delay in children.38
In conclusion, our results indicate a possible associ-
ation of schizophrenia and bipolar disorder with a CAG
repeat-containing locus on chromosome 22. This
region contains a number of interesting candidate
genes and their involvement in these disorders needs
to be evaluated further.
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